LLY

806.87

-1.43%↓

JNJ

155.12

-1.13%↓

ABBV

190.75

+0.09%↑

NVO

76.95

-3.5%↓

UNH

307.68

-1.78%↓

LLY

806.87

-1.43%↓

JNJ

155.12

-1.13%↓

ABBV

190.75

+0.09%↑

NVO

76.95

-3.5%↓

UNH

307.68

-1.78%↓

LLY

806.87

-1.43%↓

JNJ

155.12

-1.13%↓

ABBV

190.75

+0.09%↑

NVO

76.95

-3.5%↓

UNH

307.68

-1.78%↓

LLY

806.87

-1.43%↓

JNJ

155.12

-1.13%↓

ABBV

190.75

+0.09%↑

NVO

76.95

-3.5%↓

UNH

307.68

-1.78%↓

LLY

806.87

-1.43%↓

JNJ

155.12

-1.13%↓

ABBV

190.75

+0.09%↑

NVO

76.95

-3.5%↓

UNH

307.68

-1.78%↓

Search

Altimmune Inc

Suletud

6.84 -1.16

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

6.77

Max

7.35

Põhinäitajad

By Trading Economics

Sissetulek

3.6M

-20M

Müük

5K

Aktsiakasum

-0.26

Kasumimarginaal

-391,500

Töötajad

59

EBITDA

2.9M

-20M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+201.01% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

7. aug 2025

Turustatistika

By TradingEconomics

Turukapital

20M

483M

Eelmine avamishind

8

Eelmine sulgemishind

6.84

Tehniline skoor

By Trading Central

Kindlus

Bullish Evidence

Altimmune Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

16. juuni 2025, 22:33 UTC

Omandamised, ülevõtmised, äriostud

KKR to Acquire Australian Power Provider Zenith Energy

16. juuni 2025, 21:55 UTC

Suurimad hinnamuutused turgudel

Geospace Technologies Shares Up on Petrobras Pact

16. juuni 2025, 17:04 UTC

Suurimad hinnamuutused turgudel

Roku Shares Climb on Advertising Deal with Amazon

16. juuni 2025, 23:51 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

16. juuni 2025, 23:51 UTC

Market Talk

Nikkei May Trade Range Bound Amid Israel-Iran Conflict -- Market Talk

16. juuni 2025, 23:41 UTC

Market Talk

Gold Edges Higher Amid Ongoing Geopolitical Tensions -- Market Talk

16. juuni 2025, 23:10 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

XRG Has 'Viable Path' to Approval of Santos Takeover -- Market Talk

16. juuni 2025, 23:02 UTC

Market Talk

Auckland Airport Unlikely to Hit Target for International Passengers -- Market Talk

16. juuni 2025, 22:32 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Santos Unlikely to Attract Rival Bidder to XRG -- Market Talk

16. juuni 2025, 22:03 UTC

Omandamised, ülevõtmised, äriostud

KKR & Co. to Buy Zenith Energy From Consortium Including Pacific Equity Partners, OPSEU Pension Trust, Foresight Group >KKR

16. juuni 2025, 22:00 UTC

Omandamised, ülevõtmised, äriostud

KKR Acquires Leading Australian Independent Power Producer Zenith Energy >KKR

16. juuni 2025, 21:56 UTC

Tulu

Lennar Has an Earnings Miss. The Stock Slips. -- Barrons.com

16. juuni 2025, 21:10 UTC

Omandamised, ülevõtmised, äriostud

Mitsubishi in Talks to Sign $8 Billion Deal With Gas Producer Aethon -- WSJ

16. juuni 2025, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

16. juuni 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

16. juuni 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

16. juuni 2025, 20:49 UTC

Market Talk

Fitch Revises Canadian Provinces Fiscal Outlook to 'Deteriorating' -- Market Talk

16. juuni 2025, 20:14 UTC

Omandamised, ülevõtmised, äriostud

Update: EchoStar Stock Surges. It's Short Covering and President Trump. -- Barrons.com

16. juuni 2025, 20:13 UTC

Market Talk

Natural Gas Gains on Warmer Outlook -- Market Talk

16. juuni 2025, 19:58 UTC

Omandamised, ülevõtmised, äriostud

OpenAI and Microsoft Tensions Are Reaching a Boiling Point -- WSJ

16. juuni 2025, 19:13 UTC

Market Talk

Middle-East Conflict May Not Push Up Oil Long Term -- Market Talk

16. juuni 2025, 19:09 UTC

Market Talk

Amazon-Roku Deal Shows Competition for Streaming Ad Space -- Market Talk

16. juuni 2025, 18:43 UTC

Market Talk

May Could Mark Nascent Recovery in Canada Housing Market -- Market Talk

16. juuni 2025, 18:36 UTC

Market Talk

Soybeans May Get Boost from Renewable Fuel Obligations -- Market Talk

16. juuni 2025, 18:29 UTC

Market Talk

Global Equities Roundup: Market Talk

16. juuni 2025, 18:29 UTC

Market Talk

Shopify Appears More Resilient Than Feared -- Market Talk

16. juuni 2025, 18:22 UTC

Market Talk

Citi Forecasts Downturn in Gold Futures -- Market Talk

16. juuni 2025, 16:42 UTC

Market Talk

Homebuyers' Downpayments Are Shrinking For First Time in 2 Years -- Market Talk

16. juuni 2025, 16:37 UTC

Market Talk

Big, Beautiful Bill Might Not Mean Big Growth -- Market Talk

16. juuni 2025, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

Võrdlus sarnastega

Hinnamuutus

Altimmune Inc Prognoos

Hinnasiht

By TipRanks

201.01% tõus

12 kuu keskmine prognoos

Keskmine 20.83 USD  201.01%

Kõrge 25 USD

Madal 12 USD

Põhineb 7 Wall Streeti analüütiku instrumendi Altimmune Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

7 ratings

6

Osta

1

Hoia

0

Müü

Tehniline skoor

By Trading Central

5.365 / 6.0486Toetus ja vastupanu

Lühikene perspektiiv

Bullish Evidence

Keskpikk perspektiiv

Weak Bullish Evidence

Pikk perspektiiv

Bearish Evidence

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Altimmune Inc

Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, a GLP-1/glucagon dual receptor agonist that is in Phase 2 trial for the treatment of obesity and metabolic dysfunction-associated steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.